Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Will An Output Boost End Oil's Runaway Rally?

Published 05/28/2018, 07:13 AM
Updated 07/09/2023, 06:31 AM

Stocks ended lower on May 25 as crude prices plummeted. The immediate trigger for a decline in oil prices was reports that OPEC and Russia were discussing an increase in oil production. Consequently, stocks of energy companies suffered losses.

The energy sector has been on a dream run this year following OPEC and other major oil producers’ decision to extend an output controls agreement. Consequently, oil prices touched three-year highs recently. But could a reconsideration of the same agreement end crude’s spectacular rally?

Oil Prices Suffer Weekly Losses

On May 25, the price of WTI crude declined by 4% or $2.83 to end at $67.88 per barrel. This was the largest daily loss for U.S. crude price since July 2017. Currently, oil is nearly 7% lower than the recent highs above $72. This was also its lowest close since May 1. Further, prices suffered a weekly decline of 4.9%.

Additionally, Brent crude lost 3% or $2.35 to close at $76.44 per barrel. This was its lowest close since May 8. Brent crude also suffered a weekly loss of 2.6%. In recent weeks, a collapse in production in Venezuela and fears that exports from Iran will fall post Trump’s decision to exit the nuclear deal had boosted prices.

Reports of Output Increase Cause Decline

The decline in crude prices weighed on shares of energy companies. Consequently, shares of oil majors Exxon Mobil Corporation (NYSE:XOM) and Chevron Corporation (NYSE:CVX) declined 1.9% and 3.5%, respectively.

Shares of Schlumberger Limited (NYSE:SLB) and ConocoPhillips (NYSE:COP) Inc. also declined 3.7% and 4.4%, respectively. ConocoPhillips has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The immediate trigger for the decline in crude prices was reports that OPEC and key non-OPEC oil producers were considering an increase in output. On May 25, Russia’s energy minister Alexander Novak met his Saudi counterpart Khalid Al-Falih in Petersburg to discuss the output controls agreement.

Subsequently, reports emerged that an increase in production levels was being considered for the first time since 2016. The current agreement, which has been in force since January 2017, aims to limit output to 1.8 million barrels a day.

According to a report from Reuters, the planned increase in output is as high as 1 million barrels. Bloomberg has reported that output may be increased by 300,000 barrels to 800,000 barrels per day. Currently, global inventories are close to OPEC’s targeted level, another factor which has helped to boost prices to three-year highs recently.

Forecasts for Prices Remain High

Another reason for the decline in crude prices on last Friday was an increase in total active U.S. rig count. A report from Baker Hughes (NYSE:BHGE) revealed that the number of active U.S. rigs drilling for oil increased by 15 to 859 over last week. This was the biggest weekly increase since the week ended February 9.

However, despite the losses incurred on Friday Société Générale (OTC:SCGLY) revised its projections for oil prices upward. The bank now believes Brent crude will maintain an average of $72.75 in 2019, $7.75 higher than its earlier forecast. The outlook for WTI was also revised upward by $6.75 to $67.75.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The primary reason for analysts’ projections for a continuing uptrend is the massive decline in Venezuelan output. Analysts at the Paris-based bank now believe that monthly declines will continue at the current rate into 2019. The projected fall in crude supplies due to the United States’ decision to exit the Iran nuclear deal is also likely to boost prices in the medium term.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



Societe Generale (PA:SOGN

Schlumberger Limited (SLB): Free Stock Analysis Report

Chevron Corporation (CVX): Free Stock Analysis Report

Exxon Mobil Corporation (XOM): Free Stock Analysis Report

ConocoPhillips (COP): Free Stock Analysis Report

Baker Hughes Incorporated (BHGE): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.